首页> 外文OA文献 >Next generation exome sequencing of paediatric inflammatory bowel disease patients identifies rare and novel variants in candidate genes
【2h】

Next generation exome sequencing of paediatric inflammatory bowel disease patients identifies rare and novel variants in candidate genes

机译:小儿炎症性肠病患者的下一代外显子组测序可鉴定候选基因中的稀有和新颖变体

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Background Multiple genes have been implicated by association studies in altering inflammatory bowel disease (IBD) predisposition. Paediatric patients often manifest more extensive disease and a particularly severe disease course. It is likely that genetic predisposition plays a more substantial role in this group.Objective To identify the spectrum of rare and novel variation in known IBD susceptibility genes using exome sequencing analysis in eight individual cases of childhood onset severe disease.Design DNA samples from the eight patients underwent targeted exome capture and sequencing. Data were processed through an analytical pipeline to align sequence reads, conduct quality checks, and identify and annotate variants where patient sequence differed from the reference sequence. For each patient, the entire complement of rare variation within strongly associated candidate genes was catalogued.Results Across the panel of 169 known IBD susceptibility genes, approximately 300 variants in 104 genes were found. Excluding splicing and HLA-class variants, 58 variants across 39 of these genes were classified as rare, with an alternative allele frequency of <5%, of which 17 were novel. Only two patients with early onset Crohn's disease exhibited rare deleterious variations within NOD2: the previously described R702W variant was the sole NOD2 variant in one patient, while the second patient also carried the L1007 frameshift insertion. Both patients harboured other potentially damaging mutations in the GSDMB, ERAP2 and SEC16A genes. The two patients severely affected with ulcerative colitis exhibited a distinct profile: both carried potentially detrimental variation in the BACH2 and IL10 genes not seen in other patients.Conclusion For each of the eight individuals studied, all non-synonymous, truncating and frameshift mutations across all known IBD genes were identified. A unique profile of rare and potentially damaging variants was evident for each patient with this complex disease.
机译:背景技术关联研究已暗示多种基因改变了炎症性肠病(IBD)的易感性。小儿患者通常表现出更广泛的疾病和特别严重的病程。目的是通过外显子组测序分析确定8例儿童期严重疾病个体中的IBD易感性基因的稀有和新颖变异谱,并从这8例中设计DNA样本患者接受了靶向外显子组捕获和测序。通过分析流水线处理数据,以比对序列读数,进行质量检查并识别和注释患者序列与参考序列不同的变异体。对于每位患者,都对强相关候选基因内罕见变异的全部补体进行了分类。结果在169个已知IBD易感性基因组中,发现了104个基因中的大约300个变体。除剪接和HLA类变体外,这些基因中的39个中的58个变体被归类为罕见,等位基因的其他频率<5%,其中17个是新的。仅两名早发性克罗恩病患者在NOD2内表现出罕见的有害变异:先前描述的R702W变异体是一名患者的唯一NOD2变异体,而第二位患者也进行了L1007移码插入。两名患者在GSDMB,ERAP2和SEC16A基因中均存在其他潜在的破坏性突变。两名患有溃疡性结肠炎的患者表现出不同的特征:均携带了其他患者未见的BACH2和IL10基因的潜在有害变异。结论对于所研究的八位个体中的每一个,所有患者的所有同义,截断和移码突变确定了已知的IBD基因。对于这种复杂疾病的每位患者来说,罕见和潜在破坏性变体的独特特征是显而易见的。

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号